Rna transcription and maturation in skeletal muscle cells are similarly impaired in myotonic dystrophy and sarcopenia: The ultrastructural evidence

Frontiers in Aging Neuroscience

Volumn 6, Issue JUL, 2014, Pages

  Malatesta, Manuela ^a   Cardani, Rosanna ^b   Pellicciari, Carlo ^c   Meola, Giovanni ^b,d  

^a UNIVERSITY OF VERONA   (Italy)

^b IRCCS POLICLINICO SAN DONATO   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

Cell nucleus; Immunohistochemistry; Myotonic dystrophy; Sarcopenia; Splicing; Transmission electron microscopy

Indexed keywords

ARTICLE; CELL MATURATION; CELL NUCLEUS; HUMAN; MYOTONIC DYSTROPHY; PHENOTYPE; RNA TRANSCRIPTION; SARCOPENIA; SKELETAL MUSCLE SATELLITE CELL;

EID: 84904640116     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2014.00196     Document Type: Article

References (44)

1. Vihola A, Bassez G, Meola G, Zhang S, Haapasalo H, Paetau A, Mancinelli E, Rouche A, Hogrel JY, Laforêt P, Maisonobe T, Pellissier JF, Krahe R, Eymard B, Udd B. Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2. Neurology (2003) 60:1854-7.
2. Meola G, Moxley RT 3rd. Myotonic dystrophy type 2 and related myotonic disorders. J Neurol (2004) 251:1173-82.
3. Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, Hunter K, Stanton VP, Thirion JP, Hudson T, Sohn R, Zemelman B, Snell RG, Rundle SA, Crow S, Davies J, Shelbourne P, Buxton J, Jones C, Juvonen V, Johnson K, Harper PS, Shaw DJ, Housman DE. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell (1992) 69:385-7. doi: 10.1016/0092-8674(92)90154-5
4. Fu YH, Pizzuti A, Fenwick RG Jr, King J, Rajnarayan S, Dunne PW, Dubel J, Nasser GA, Ashizawa T, de Jong P, Wieringa B, Korneluk R, Perryman MB, Epstein HF, Caskey CT,. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science (1992) 255:1256-8. doi: 10.1126/science.1546326
5. Mahadevan M, Tsilfidis C, Sabourin L, Shutler G, Amemiya C, Jansen G, Neville C, Narang M, Barceló J, O'Hoy K, Leblond S, Earle-MacDonald J, de Jong PJ, Wieringa B, Korneluk RG. Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. Science (1992) 255:1253-5. doi: 10.1126/science.1546325
6. Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, Day JW, Ranum LP. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science (2001) 293:864-7. doi: 10.1126/science.1062125
7. Ranum LP, Rasmussen PF, Benzow KA, Koob MD, Day JW. Genetic mapping of a second myotonic dystrophy locus. Nat Genet (1998) 19:196-8. doi:10.1038/570
8. Ryall JG, Schertzer JD, Lynch GS. Cellular and molecular mechanisms underlying age-related skeletal muscle wasting and weakness. Biogerontol (2008) 9:213-28. doi: 10.1007/s10522-008-9131-0
9. Thompson LV. Age-related muscle dysfunction. Exp Gerontol (2009) 44:106-11. doi: 10.1016/j.exger.2008.05.003
10. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M; European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing (2010) 39:412-23. doi: 10.1093/ageing/afq034
11. Lexell J. Human aging, muscle mass, and fibre type composition. J Gerontol A Biol Sci Med Sci (1995) 50:11-6.
12. Edstrom E, Altun M, Bergman E, Johnson H, Kullberg S, Ramírez-León V, Ulfhake B. Factors contributing to neuromuscular impairment and sarcopenia during aging. Physiol Behav (2007) 92:129-35. doi: 10.1016/j.physbeh.2007.05.040
13. Verdijk LB, Koopman R, Schaart G, Meijer K, Savelberg HH, van Loon LJ. Satellite cell content is specifically reduced in type II skeletal muscle fibers in the elderly. Am J Physiol Endocrinol Metab (2007) 292:E151-7. doi: 10.1152/ajpendo.00278.2006
14. Wahle E, Rüegsegger U. 3'-end processing of pre-mRNA in eukaryotes. FEMS Microbiol Rev (1999) 23:277-95.
15. Fakan S. Ultrastructural cytochemical analyses of nuclear functional architecture. Eur J Histochem (2004) 48:5-14.
16. Cmarko D, Verschure PJ, Martin TE, Dahmus ME, Krause S, Fu XD, van Driel R, Fakan, S. Ultrastructural analysis of transcription and splicing in the cell nucleus after bromo-UTP microinjection. Mol Biol Cell (1999) 10:211-23.
17. Schul W, Groenhout B, Koberna K, Takagaki Y, Jenny A, Manders EM, Raska I, van Driel, R, de Jong L. The RNA 3' cleavage factors CstF 64 kDa and CPSF 100 kDa are concentrated in nuclear domains closely associated with coiled bodies and newly synthesized RNA. Embo J (1996) 15:2883-92.
18. Bogolyubov D, Stepanova I, Parfenov V. Universal nuclear domains of somatic and germ cells: some lessons from oocyte interchromatin granule cluster and Cajal body structure and molecular composition. Bioessays (2009) 31:400-9. doi: 10.1002/bies.200800100
19. Biggiogera M, Cisterna B, Spedito A, Vecchio L, Malatesta M. Perichromatin fibrils as early markers of transcriptional alterations. Differentiation (2008) 76:57-65. doi: 10.1111/j.1432-0436.2007.00211.x
20. Malatesta M, Biggiogera M, Cisterna B, Balietti M, Bertoni-Freddari C, Fattoretti P. Perichromatin fibrils accumulation in hepatocyte nuclei reveals alterations of pre-mRNA processing during ageing. DNA Cell Biol (2010) 29:49-57. doi: 10.1089/dna.2009.0880
21. Taneja KL, McCurrach M, Schalling M, Housman D, Singer RH. Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J Cell Biol (1995) 128:995-1002.
22. Mankodi A, Teng-Umnuay P, Krym M, Henderson D, Swanson M, Thornton CA. Ribonuclear inclusions in skeletal muscle in myotonic dystrophy types 1 and 2. Ann Neurol (2003) 54:760-8 DOI: 10.1002/ana.10763
23. Cardani R, Mancinelli E, Rotondo G, Sansone V, Meola G. Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2. Eur J Histochem (2006) 50:177-82.
24. Llorian M, Smith CWJ. Decoding muscle alternative splicing. Curr Opin Genet Develop (2011) 21:380-7. doi: 10.1016/j.gde.2011.03.006
25. Meola G, Cardani R. Myotonic Dystrophies: an update on clinical aspects, genetic, pathology and molecular pathomechanisms. Biochim Biophys Acta (2014) in press. pii: S0925-4439(14)00147-1. doi: 10.1016/j.bbadis.2014.05.019
26. Giagnacovo M, Malatesta M, Cardani R, Meola G, Pellicciari C. Nuclear ribonucleoprotein278 containing foci increase in size in non-dividing cells from patients with myotonic dystrophy type 2. Histochem Cell Biol (2012) 138:699-707. doi: 10.1007/s00418-012-0984-6
27. Perdoni F, Malatesta M, Cardani R, Giagnacovo M, Mancinelli E, Meola G, Pellicciari C. RNA/MBNL1-containing foci in myoblast nuclei from patients affected by myotonic dystrophy type 2: an immunocytochemical study. Eur J Histochem (2009) 53:151-8.
28. Malatesta M, Giagnacovo M, Costanzo M, Cisterna B, Cardani R, Meola G. Muscleblind-like1 undergoes ectopic relocation in the nuclei of skeletal muscles in myotonic dystrophy and sarcopenia. Eur J Histochem (2013) 57:e15. doi: 10.4081/ejh.2013.e15
29. Malatesta M, Giagnacovo M, Cardani R, Meola G, Pellicciari C. RNA processing is altered in skeletal muscle nuclei of patients affected by myotonic dystrophy. Histochem. Cell Biol (2011)135:419-25. doi: 10.1007/s00418-011-0797-z
30. Salisbury E, Schoser B, Schneider-Gold C, Wang GL, Huichalaf C, Jin B, Sirito M, Sarkar P, Krahe R, Timchenko NA, Timchenko LT. Expression of RNA CCUG repeats dysregulates translation and degradation of proteins in myotonic dystrophy 2 patients. Am J Pathol (2009) 175:748-62. doi: 10.2353/ajpath.2009.090047
31. Huichalaf C, Sakai K, Jin B, Jones K, Wang GL, Schoser B, Schneider-Gold C, Sarkar P, Pereira-Smith OM, Timchenko N, Timchenko L. Expansion of CUG RNA repeats causes stress and inhibition of translation in myotonic dystrophy 1 (DM1) cells. FASEB J (2010) 24:3706-19. doi: 10.1096/fj.09-151159
32. Malatesta M, Giagnacovo M, Renna LV, Cardani R, Meola G, Pellicciari C. Cultured myoblasts from patients affected by myotonic dystrophy type 2 exhibit senescence-related features: ultrastructural evidence. Eur J Histochem (2011) 55:e26. doi: 10.4081/ejh.2011.e26
33. Giagnacovo M, Costanzo M, Cardani R, Veneroni P, Pellicciari C, Meola G. In vitro aging of myotubes derived from myoblasts of patients affected by myotonic dystrophy type 2 (DM2): ultrastructural evidence. Microscopie (2011) 16:60-7.
34. Malatesta M, Perdoni F, Muller S, Zancanaro C, Pellicciari C. Nuclei of aged myofibres undergo structural and functional changes suggesting impairment in RNA processing. Eur J Histochem (2009) 53:197-206.
35. Malatesta M, Fattoretti P, Giagnacovo M, Pellicciari C, Zancanaro C. Physical training modulates structural and functional features of cell nuclei in type II myofibers of old mice. Rejuvenation Res (2011) 14:543-52. doi: 10.1089/rej.2011.1175. doi: 10.1089/rej.2011.1175
36. Bertoni-Freddari C, Fattoretti P, Malatesta M. Increased intracellular ionic content is correlated with a decreased perichromatin granule density in old neurones. Ann N Y Acad Sci (2004) 1030:289-96. doi: 10.1196/annals.1329.036
37. Malatesta M, Baldelli B, Battistelli S, Fattoretti P, Bertoni-Freddari C. Aging affects the distribution of the circadian CLOCK protein in rat hepatocytes. Microsc Res Tech (2005) 68:45-50. doi: 10.1002/jemt.20221
38. Malatesta M, Fattoretti P, Baldelli B, Battistelli S, Balietti M, Bertoni-Freddari C. Effects of ageing on the fine distribution of the circadian CLOCK protein in reticular formation neurons. Histochem Cell Biol (2007) 127:641-7. doi: 10.1007/s00418-007-0284-8
39. Koopman R, van Loon LJC. Aging, exercise and muscle protein metabolism. J Appl Physiol (2009) 106:2040-8. doi: 10.1152/japplphysiol.91551.2008
40. Malatesta M, Perdoni F, Muller S, Pellicciari C, Zancanaro C. Pre-mRNA processing is partially impaired in satellite cell nuclei from aged muscles. J Biomed Biotechnol (2010) 410405. doi: 10.1155/2010/410405
41. Malatesta M, Meola G. Structural and functional alterations of the cell nucleus in skeletal muscle wasting: the evidence in situ. Eur J Histochem (2010) 54:e44. doi: 10.4081/ejh.2010.e44
42. Malatesta M. Skeletal muscle features in myotonic dystrophy and sarcopenia: do similar nuclear mechanisms lead to skeletal muscle wasting? Eur J Histochem (2012) 56:e36. doi: 10.4081/ejh.2012.e36
43. Kanadia RN, Johnstone KA, Mankodi A, Lungu C, Thornton CA, Esson D, Timmers AM, Hauswirth WW, Swanson MS. A muscleblind knockout model for myotonic dystrophy. Science (2003) 302: 1978-80. doi: 10.1126/science.1088583
44. Martin TE, Jones R, Billings P. hnRNP core proteins: synthesis, turnover and intracellular distribution. Mol Biol Rep (1979) 5:37-42.